Vitamin B12
- Generic Name
- Vitamin B12
- Brand Names
- Infuvite Pediatric, Mvc-fluoride, Animi-3 With Vitamin D, Dodex, Fortaplex, Irospan 24/6 Kit, Cobex, Natafort, Infuvite, Vitafol-one, Nascobal, Mvi Pediatric, Hematogen, Folbic, Ferralet 90, Foltabs, Concept Ob, Pregvit, Tandem Plus, B-12
- Drug Type
- Small Molecule
- Chemical Formula
- C62H88CoN13O14P
- CAS Number
- 13408-78-1
- Unique Ingredient Identifier
- 8406EY2OQA
- Background
Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria , and is necessary for DNA synthesis and cellular energy production. Vitamin B12 has many forms, including the cyano-, methyl-, deoxyadenosyl- and hydroxy-cobala...
- Indication
Nasal spray
The cyanocobalamin nasal spray is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with deficiency of this vitamin who have no nervous system involvement .
...
- Associated Conditions
- Neuritis, Vitamin Deficiency, Vitamin B6 Deficiency, Diabetic Neuropathies, Vitamin B1 deficiency, Anemia, Pernicious, Vitamin B12 Deficiency, Convalescence, Iron Deficiency Anemia (IDA), Folate deficiency, Combined Vitamin B1 and B12 deficiency, Vitamin B12 concentration, Anemia
- Associated Therapies
- Vitamin supplementation, Nutritional supplementation
Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2014-09-08
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 132
- Registration Number
- NCT01876732
- Locations
- 🇺🇸
Island Rehab, Staten Island, New York, United States
Intracoronary Administration of Levosimendan in Cardiac Surgery Patients
- First Posted Date
- 2011-12-28
- Last Posted Date
- 2019-09-13
- Lead Sponsor
- Tampere University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT01500785
- Locations
- 🇫🇮
Heart Center Co. Tampere university hospital, Tampere, Finland
China Stroke Secondary Prevention Trial
- Conditions
- Interventions
- First Posted Date
- 2011-03-17
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Xijing Hospital
- Registration Number
- NCT01317849
- Locations
- 🇨🇳
Xijing Hosptial, Xi'an, Shanxi, China
Oral Cyanocobalamin (Eligen B12) Bioavailability Study
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2011-03-09
- Lead Sponsor
- Emisphere Technologies, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01311739
A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-07-19
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 19
- Registration Number
- NCT01165021
- Locations
- 🇮🇹
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sondalo, Italy
Dietary Supplements for the Treatment of Angelman Syndrome
- Conditions
- Interventions
- First Posted Date
- 2006-07-06
- Last Posted Date
- 2012-09-24
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 90
- Registration Number
- NCT00348933
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸Rady Children's Hospital San Diego, San Diego, California, United States
🇺🇸Children's Hospital Boston, Boston, Massachusetts, United States
How Many Patients Are in Need of Vitamin B12 Injections?
- Conditions
- First Posted Date
- 2006-05-17
- Last Posted Date
- 2008-08-08
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 50
- Registration Number
- NCT00326833
- Locations
- 🇩🇰
Anne-Mette Hvas, Aarhus N, Denmark
The Norwegian Vitamin Trial (NORVIT)
- Conditions
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- University of Tromso
- Target Recruit Count
- 3750
- Registration Number
- NCT00266487
- Locations
- 🇳🇴
Institute of Community Medicine, University of Tromsø, Tromsø, Norway
Phase 2 Trial of Bevacizumab in Combination With Pemetrexed
- Conditions
- Interventions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Heather Wakelee
- Target Recruit Count
- 16
- Registration Number
- NCT00227019
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
🇺🇸Cooper Cancer Institute, Voorhees, New Jersey, United States
Effects of Vitamin B12 on the Body's Internal Clock
- Conditions
- First Posted Date
- 2005-07-18
- Last Posted Date
- 2010-01-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT00120484
- Locations
- 🇺🇸
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.